All articles

Pregnenolone: 'Mother of All Hormones' for Burnout and Chronic Fatigue

Pregnenolone: 'Mother of All Hormones' for Burnout and Chronic Fatigue

Introduction: The Forgotten Hormone

Pregnenolone is a steroid hormone synthesized from cholesterol in the mitochondria of the adrenal cortex, gonads, and central nervous system. It is the starting precursor of absolutely all steroid hormones: DHEA, cortisol, aldosterone, testosterone, estradiol, and progesterone. This is why it is called the "mother of all hormones."

Despite its fundamental role, pregnenolone remains one of the least studied and prescribed hormones in clinical practice. Its levels begin declining at age 30, losing approximately 1-2% annually. By age 75, pregnenolone concentration is only 40% of the level at age 35 (Journal of Clinical Endocrinology & Metabolism, 2004).

Biosynthesis: From Cholesterol to the Steroid Cascade

Pregnenolone synthesis begins with cholesterol transport across the outer mitochondrial membrane by StAR protein (Steroidogenic Acute Regulatory protein). The enzyme CYP11A1 (P450scc) then cleaves the side chain of cholesterol, converting it to pregnenolone.

Pregnenolone then metabolizes through two main pathways: 1) the delta-5 pathway: pregnenolone to 17-OH-pregnenolone to DHEA to androstenedione to testosterone/estradiol; 2) the delta-4 pathway: pregnenolone to progesterone to 17-OH-progesterone to cortisol/aldosterone.

During chronic stress, the "pregnenolone steal" phenomenon occurs: the body redirects all available pregnenolone toward cortisol synthesis at the expense of DHEA, testosterone, and progesterone. This explains the characteristic hormonal profile in burnout: high cortisol with low DHEA, testosterone, and progesterone.

Pregnenolone as a Neurosteroid

Pregnenolone and its metabolites (pregnenolone sulfate, allopregnanolone) are among the most potent neurosteroids — substances synthesized directly in the brain that modulate neuronal activity.

Pregnenolone sulfate is a positive modulator of NMDA receptors, enhancing neuroplasticity, memory formation, and cognitive function. A study in PNAS (2013) showed that hippocampal pregnenolone sulfate levels correlate with working memory performance.

Allopregnanolone is a potent positive modulator of GABA-A receptors, possessing anxiolytic, sedative, and neuroprotective properties. Brexanolone (Zulresso), a synthetic allopregnanolone analogue, was FDA-approved in 2019 for postpartum depression — the first neurosteroid to receive regulatory approval.

Pregnenolone in Burnout and Chronic Fatigue

The Neuroendocrinology of Burnout

Burnout is characterized by three stages of HPA axis dysregulation: 1) alarm stage — elevated cortisol and adrenaline; 2) resistance stage — cortisol normalizes but DHEA and pregnenolone decline; 3) exhaustion stage — low cortisol, low DHEA, low pregnenolone.

A systematic review in Psychoneuroendocrinology (2019) showed that the cortisol/DHEA ratio in burnout patients differs significantly from healthy controls. Pregnenolone, as the precursor of both, is a strategic intervention point.

Clinical Evidence

A pilot study in Journal of Psychiatry & Neuroscience (2014): pregnenolone at 500 mg/day significantly improved cognitive function. Marx et al. (Psychopharmacology, 2009): 400 mg/day increased allopregnanolone levels by 200-300% and improved verbal memory.

When to Evaluate Pregnenolone

  • Chronic fatigue not explained by other causes - Professional burnout with cognitive impairment ("brain fog") - Reduced stress resilience and emotional lability - Low DHEA with normal or elevated cortisol - Decreased libido combined with fatigue - Age-related cognitive decline

Diagnostic Testing

Serum Pregnenolone — morning fasting sample (8:00-10:00 AM). Reference ranges: males 22-237 ng/dL, females 11-204 ng/dL. Optimal: upper third of range. DHEA-Sulfate — mandatory alongside pregnenolone. Morning Cortisol — to assess HPA axis function. Expanded Steroid Panel (LC-MS/MS) — complete steroid metabolism picture.

Treatment Protocol

RegimenDose
Starting5-15 mg/day
Standard (burnout)25-50 mg/day
Therapeutic50-100 mg/day
Researchup to 500 mg/day

Synergistic Agents

  • Vitamin B5 (Pantothenic Acid): 500 mg/day — cofactor for steroidogenesis - Vitamin C: 1,000 mg/day — adrenal support - Magnesium Bisglycinate: 300-400 mg/day - Adaptogens: ashwagandha (300-600 mg KSM-66), rhodiola rosea (200-400 mg) - Phosphatidylserine: 100-300 mg/day — lowers evening cortisol

Safety

Frequently Asked Questions

Is pregnenolone a hormone or a supplement? It is an endogenous steroid hormone. In the USA it is available OTC. In Europe a prescription may be required. Use under physician supervision with hormone monitoring.

Can pregnenolone increase testosterone? Yes, theoretically, through the metabolic cascade. However, conversion is unpredictable — depends on body needs. Monitoring is essential.

How does pregnenolone steal differ from adrenal insufficiency? Pregnenolone steal is functional redistribution, not organic damage. Addison's disease is autoimmune adrenal destruction with critically low cortisol.

Is pregnenolone suitable for women? Yes, considering menstrual cycle phase. Start in the luteal phase. In PCOS — caution due to possible androgen conversion.

This article is for informational purposes only. Pregnenolone is a hormonal agent. Consultation with an endocrinologist and laboratory testing are mandatory before use.

🌀

Hepatic and Renal Safety Monitoring

Although pregnenolone is generally well tolerated at physiological replacement doses, oral administration undergoes first-pass hepatic metabolism, and the contraindication for severe liver disease implies a monitoring obligation in all treated patients.

Baseline laboratory panel (before initiation). ALT, AST, GGT, alkaline phosphatase, total and direct bilirubin, albumin, complete blood count, creatinine with eGFR, urea, urinalysis, and lipid panel. Hepatitis B surface antigen and hepatitis C antibody screening are reasonable in patients with risk factors or unexplained transaminase elevation.

Red-flag symptoms requiring immediate evaluation. Right upper quadrant pain, jaundice, dark urine, pruritus, persistent nausea, peripheral edema, or new hypertension demand pause and reassessment regardless of scheduled monitoring intervals.

🌀

Age- and Sex-Stratified Dosing Considerations

Endogenous pregnenolone declines approximately 1–2% annually after age 30, with steeper drops after age 50 in both sexes PMID: 12700375. However, age alone does not justify supplementation; clinical context, biochemistry, and symptom burden govern the decision. Stratification refines starting dose and target ranges.

In all groups, the principle of "lowest effective dose for the shortest justified duration" supersedes any age-based template. Periodic reassessment every 8–12 weeks prevents indefinite therapy in patients whose clinical state has shifted.

References

  1. PMID: 12700375. PMID 12700375
Key facts
  • Pregnenolone is the precursor to all steroid hormones: DHEA, cortisol, testosterone, estradiol, and progesterone.
  • Synthesized from cholesterol in mitochondria; the enzyme CYP11A1 (P450scc) cleaves the cholesterol side chain.
  • Under chronic stress, "pregnenolone steal" redirects pregnenolone to cortisol at the expense of DHEA and sex hormones.
  • Levels decline from age 30 by 1-2% annually; by age 75 only about 40% of the level at age 35.
  • Serum pregnenolone reference: males 22-237 ng/dL, females 11-204 ng/dL (morning fasting sample).

Frequently asked questions

Pregnenolone is a steroid hormone synthesized from cholesterol in the mitochondria of the adrenal cortex, gonads, and central nervous system. It is the primary precursor of absolutely all steroid hormones: DHEA, cortisol, aldosterone, testosterone, estradiol, and progesterone. This upstream position in the steroid cascade is precisely what gave it the name 'mother of all hormones'.

Under chronic stress, the body redirects all available pregnenolone toward cortisol synthesis at the expense of DHEA, testosterone, and progesterone — this is the phenomenon known as 'pregnenolone steal'. It explains the characteristic hormonal profile seen in burnout: elevated cortisol alongside low DHEA, testosterone, and progesterone. Unlike Addison's disease, this is a functional redistribution, not an organic lesion of the adrenal cortex.

Pregnenolone levels begin to decline around age 30, falling by approximately 1–2% per year. By age 75, the concentration is only about 40% of the level seen at age 35. This age-related decline is cited among the indications for pregnenolone assessment in cognitive impairment.

Pregnenolone and its metabolites are among the most potent neurosteroids synthesized directly in the brain. Pregnenolone sulfate is a positive modulator of NMDA receptors, enhancing neuroplasticity, memory formation, and cognitive function; its level in the hippocampus correlates with measures of working memory. Allopregnanolone is a potent modulator of GABA-A receptors with anxiolytic, sedative, and neuroprotective effects.

The article cites the following dose ranges: an initial (microdosing) dose of 5–15 mg/day taken in the morning, a standard burnout dose of 25–50 mg/day, and a therapeutic dose of 50–100 mg/day under medical supervision. Clinical studies have used doses up to 500 mg/day. Adverse effects — acne, irritability, insomnia, and headache — occur primarily at doses above 100 mg and resolve upon dose reduction.

Share
Follow on TelegramGet new articles, research updates and practical health tips
Читать на русскомЧитати українською

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions. Full disclaimer

Ready to Take Action?

A consultation starts where the article ends: your history, your labs, a plan for your case.

Book consultationAsk a question